跳至主要内容
临床试验/IRCT2015110624903N1
IRCT2015110624903N1已完成4 期

investigation of the effectiveness of combination of losartan with Rocaltrol on treatment of albuminuria in patient with diabetic nephropathy; a clinical trial.

Arak University of Medical Sciences0 个研究点目标入组 132 人开始时间: 待定最近更新:
适应症

试验速览

阶段
4 期
状态
已完成
入组人数
132

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
40 years 至 70 years(—)
性别
All

入选标准

  • aged between 40-70 years; diabetes mellitus type 2 that at least 3 months past diagnosis; Albuminuria is (urinary albumin >30 mg/24 hours); Signing Informed consent form; ca <9.5 and p <5.5; Not having an active urine analysis regarding Hematuria, pyuria and urine cast or crystal.
  • Exclusion criteria: K > 5.5 mg per deciliter or creatinine rising more than 30% after administration of Losartan; administration of vitamin D agents; acute infectious disease; acute heart failure; cancer; pregnancy; Urinary protein more than 8 gr/24 hours; vitamin D deficiency.

排除标准

  • 未提供

研究者

相似试验